Recent updates

Browse recent updates. BMJ Best Practice is continuously updated to provide the latest evidence-based decision support.

  • 30 Sep 2022FDA approves tapinarof for adults with plaque psoriasisTopic:Psoriasis
  • 23 Sep 2022FDA and EMA approve baricitinib to treat severe alopecia areata in adultsTopic:Alopecia areata
  • 22 Sep 2022Multi-country monkeypox outbreak (2022)Topic:Monkeypox
  • 16 Sep 2022WHO recommends monoclonal antibodies for the treatment of Ebola virus infectionTopic:Ebola virus infection
  • 25 Aug 2022New US guidance includes updated recommendations on classification of heart failure, prevention, and treatment of symptomatic diseaseTopic:Acute heart failure
  • 09 Aug 2022Vaccine derived poliovirus (VDPV) detected in New York, London, and JerusalemTopic:Poliovirus infection
  • 05 Aug 2022Guidelines recommend measures to manage acute and chronic conditions during the COVID-19 pandemic: updatedTopic:Management of coexisting conditions in the context of COVID-19
  • 07 Jun 2022ICD-11 represents major shift in the classification of gender identity-related healthTopic:Gender dysphoria in adults
  • 27 May 2022ACIP updates rabies pre-exposure prophylaxis guidelinesTopic:Rabies
  • 26 May 2022Recommendations for adjuvant therapy for stage 2 colon cancer from the American Society of Clinical Oncology (ASCO)Topic:Colorectal cancer
  • 19 Apr 2022Universal hepatitis B vaccination recommended in adults 19 to 59 yearsTopic:Hepatitis B
  • 05 Apr 2022Updated US guideline highlights importance of early surgery and interdisciplinary care to improve outcomes in older people with hip fracturesTopic:Hip fractures
  • 30 Mar 2022New US guideline on coronary artery revascularization recommends a shorter 1- to 3-month duration of dual antiplatelet therapy after percutaneous coronary intervention in select patientsTopic:Non-ST-elevation myocardial infarction
  • 30 Mar 2022US FDA approves new treatments for hemolytic anemiaTopic:Hemolytic anemia
  • 29 Mar 2022New US guideline on coronary artery revascularization recommends a shorter 1- to 3-month duration of dual antiplatelet therapy after percutaneous coronary intervention in select patientsTopic:ST-elevation myocardial infarction
  • 22 Mar 2022US guidelines on the diagnosis and evaluation of chest painTopic:Unstable angina
  • 15 Mar 2022Updated US guidelines on antithrombotic therapy for VTETopic:Pulmonary embolism